It must have seemed like a done deal. Daiichi Sankyo was so confident that its safer, more effective version of Lyrica (pregabalin) called Mirogabalin was going to beat the pants off the best-selling drug for FM. How confident were they? They funded easily the largest...
The National Pain Report recently released the results of its fibromyalgia survey examining treatment effectiveness and other questions. Almost 1,500 people participated. (Please note that the percentages in this table are different from those in the National Pain...
Lyrica was tested in mice models before it was tested in humans. Recently a substance found in wine called resveratrol took on Lyrica in a fibromyalgia mouse model test and guess what – resveratrol appeared to be more effective at reducing neuroinflammation than...
A recent analysis of the chronic fatigue syndrome treatment citations produced over the past three years indicated that behavioral studies, in particular, cognitive behavioral therapy (CBT) studies, dominated the ME/CFS treatment field. Behavioral studies tended to...
It’s not often that you see a 1,000 person drug trial for fibromyalgia or any other disease but one recently begun in the U.S. and Canada. A Japanese drug company, Daiichi Sankyo, is making a huge bet on a new drug called mirogabalin for fibromyalgia and other...
Stay Up to Date with ME/CFS, Long COVID and Fibromyalgia News
Get Health Rising's free blogs featuring the latest findings and treatment options for the ME/CFS, long COVID, fibromyalgia and complex chronic disease communities.